Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: A double-blind crossover study investigating pharmacokinetics and impact on the endometrium

Loreti, S., Thiele, K., De Brucker, M., Olsen, C., Centelles-Lodeiro, J., Bourgain, C., Waelput, W., Tournaye, H., Griesinger, G., Raes, J., Vieira-Silva, S., Arck, P., Blockeel, C., & Mackens, S. (2024). Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: A double-blind crossover study investigating pharmacokinetics and impact on the endometrium. Human Reproduction, 39(2), 403-412. https://doi.org/10.1093/humrep/dead256 (Original work published 2023)